| Home | E-Submission | Sitemap | Editorial Office |  
top_img
         
REVIEW ARTICLE 2024 December 19
Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 4: Liver and locally recurrent rectal cancer
In this paper, we review the use of hypofractionated radiotherapy for gastrointestinal malignancies, focusing on primary and metastatic liver cancer, and recurrent rectal cancer. Technological advancements in radiotherapy have facilitated the direct delivery of high-dose radiati...
ORIGINAL ARTICLE 2024 October 25
Decoding the influence of external beam radiotherapy to brachytherapy duration and overall treatment on response and early recurrences in cervical cancer patients treated with chemoradiation
Purpose: Cervical cancer is a significant global health issue affecting approximately 600,000 women each year. This study aimed to address the knowledge gaps surrounding the influence of treatment time parameters, including the duration of external beam radiotherapy (EBRT) to br...
ORIGINAL ARTICLE 2024 December 23
Lymphopenia is an adverse prognostic factor in rectal adenocarcinoma patients receiving long-course chemoradiotherapy
Purpose: Neoadjuvant radiotherapy (RT) or chemoradiotherapy (CRT) is the standard treatment for locally advanced rectal adenocarcinoma. The recent emerging data on preoperative immunotherapy as an effective therapeutic modality for mismatch repair deficient rectal carcinomas sug...
ORIGINAL ARTICLE 2024 September 19
Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients: a real-world single institution experience
Purpose: Treatment outcomes of locally advanced rectal cancer have improved significantly in recent decades. This retrospective study aimed to assess the efficacy of neoadjuvant chemoradiotherapy (nCRT) followed by surgery in patients with T4 rectal cancer and the different outc...
ORIGINAL ARTICLE 2024 December 24
Role of memantine to mitigate radiation-induced cognitive dysfunction in brain metastasis patient receiving whole brain radiotherapy: a systematic review
Purpose: Identifying comprehensively the evidence of neuroprotective effects of memantine for preserving cognitive function in brain metastasis patients receiving whole brain radiotherapy (WBRT). Methods: We searched randomized clinical trials (RCTs) analyzing the effects of me...
ORIGINAL ARTICLE 2024 December 20
The first Korean carbon-ion radiation therapy facility: current status of the Heavy-ion Therapy Center at the Yonsei Cancer Center
Purpose: This report offers a detailed examination of the inception and current state of the Heavy-ion Therapy Center (HITC) at the Yonsei Cancer Center (YCC), setting it apart as the world’s first center equipped with a fixed beam and two superconducting gantries for carbon-io...
ORIGINAL ARTICLE 2024 December 16
Radiation therapy volumes after primary systemic therapy in breast cancer patients: an international EUBREAST survey
Purpose: After primary systemic therapy (PST), agreement on the extent of locoregional therapy is lacking in breast cancer patients who convert from a node-positive to a node-negative status. The aim of this survey was to investigate radiation therapy approaches after PST accord...
ORIGINAL ARTICLE 2024 December 24
Reinforcing treatment and evaluation workflow of stereotactic ablative body radiotherapy for refractory ventricular tachycardia
Purpose: Cardiac radioablation is a novel, non-invasive treatment for ventricular tachycardia (VT), involving a single fractional stereotactic ablative body radiotherapy (SABR) session with a prescribed dose of 25 Gy. This complex procedure requires a detailed workflow and strin...
CASE REPORT 2024 December 20
Left atrial myxoma metastasizing to the brain: a case report and review of literature
Cardiac myxomas, the most common primary cardiac tumors, are believed to originate from multipotent mesenchymal cells. Approximately 75% of myxomas occur within the left atrium, increasing the risk of systemic thromboembolic events. While typically benign, atrial myxomas can rar...

If anyone registers his/her email address, he or she will receive the email of notification when new paper is published in the web site of Radiation Oncology Journal. Since it is open access journal, the full text is freely available.
Please Sign up.
Current Issue
Volume 42(4); December 2024
Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 4: Liver and locally recurrent rectal cancer
Hwa Kyung Byun, Gyu Sang Yoo, Soo-Yoon Sung, Jin-Ho Song, Byoung Hyuck Kim, et al.
Radiat Oncol J. 2024;42(4):247-256.

Review Article

December 19, 2024

Decoding the influence of external beam radiotherapy to brachytherapy duration and overall treatment on response and early recurrences in cervical cancer patients treated with chemoradiation
Abhishek Krishna, Bharat Sai Makkapatti, M. S. Athiyamaan, Dilson Lobo, Challapalli Srinivas, et al.
Radiat Oncol J. 2024;42(4):257-262.

Original Article

October 25, 2024

Lymphopenia is an adverse prognostic factor in rectal adenocarcinoma patients receiving long-course chemoradiotherapy
Ioannis M. Koukourakis, Ioannis Georgakopoulos, Dimitra Desse, Dina Tiniakos, Vassilios Kouloulias, et al.
Radiat Oncol J. 2024;42(4):263-272.

Original Article

December 23, 2024

Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients: a real-world single institution experience
Reza Ghalehtaki, Kasra Kolahdouzan, Guglielmo Niccolò Piozzi, Saeid Rezaei, Zoha Shaka, et al.
Radiat Oncol J. 2024;42(4):273-280.

Original Article

September 19, 2024

The first Korean carbon-ion radiation therapy facility: current status of the Heavy-ion Therapy Center at the Yonsei Cancer Center
Min Cheol Han, Seo Hee Choi, Chae-Seon Hong, Yong Bae Kim, Woong Sub Koom, et al.
Radiat Oncol J. 2024;42(4):295-307.

Original Article

December 20, 2024

Radiation therapy volumes after primary systemic therapy in breast cancer patients: an international EUBREAST survey
Maria Luisa Gasparri, Orit Kaidar-Person, Oreste Davide Gentilini, Jana de Boniface, Thorsten Kuehn, et al.
Radiat Oncol J. 2024;42(4):308-318.

Original Article

December 16, 2024

Reinforcing treatment and evaluation workflow of stereotactic ablative body radiotherapy for refractory ventricular tachycardia
Hojin Kim, Sangjoon Park, Jihun Kim, Jin Sung Kim, Dong Wook Kim, et al.
Radiat Oncol J. 2024;42(4):319-329.

Original Article

December 24, 2024

Left atrial myxoma metastasizing to the brain: a case report and review of literature
Anna Basu, Natalie Grindrod, A. Rashid Dar, Andrew Leung, Matt Cecchini, et al.
Radiat Oncol J. 2024;42(4):330-334.

Case Report

December 20, 2024

E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
Journal Impact Factor 1.8
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Elekta Korea
DAWON MEDAX
Editorial Office
Department of Radiation Oncology, Samsung Medical Center,
Proton Therapy Center, B2, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea
Tel : +82-2-3410-3617
E-mail: rojeditor@gmail.com, roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next